Sarah Gheuens, Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 22,981 shares at $37.93 ($872K) on 2025-07-09, disclosed to the SEC on 2025-07-11.
Scheduled sale ($872k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.93 | 11,067 | $420K | 48.1% |
| 2 | $37.93 | 11,067 | $420K | 48.1% |
| 3 | $38.76 | 847 | $33K | 3.8% |
| Total | $37.96 avg | 22,981 | $872K | 100% |
| Filing → |
| AGIO | SELL | 2026-04-06 | $102K | — | Filing → |
| AGIO | SELL | 2026-03-03 | $83K | — | Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |